We recently attended the International Longevity and Cryopreservation Summit in Madrid. LEAF director Elena Milova caught up with futurist David Wood at the summit to ask him about his work and his views on the development of rejuvenation biotechnology.

David Wood is a famous expert in the field of architecting, designing, and implementing smart mobile devices. At the very beginning of the rise of this industry, he co-founded Symbian, the creator of the world’s first successful smartphone operating system.

David’s skills include software development, technical consulting, developer evangelism, ecosystem management, research and innovation. The EPOC32 mobile operating system he helped to architect was used in half a billion smartphones between 2001 and 2012.

Today, David acts as independent futurist, consultant, and writer, at Delta Wisdom.  

David is the Chair of the London Futurists, a group organizing regular public meetings to discuss the future and how technology and science will change the world we live in. It is their aim to engage and educate the public about science and foster better understanding for what is credible in science and what is not.

He is the author of the recent book “The Abolition of Aging: The forthcoming radical extension of healthy human longevity”, a book covering rejuvenation biotechnology published in 2016. The book discusses the various bottlenecks, concerns, and technologies relevant to the field of rejuvenation biotechnology.

The hope is that readers can learn and be more informed about these technologies that could radically change society in the near future. If you are new to the subject, we recommend reading this book for an excellent high-level view of the field, the progress. and the social issues that surround its development.

In this interview, David talks about the bottlenecks to progress in rejuvenation biotechnology and some of the potential issues we might face in developing therapies that address age-related diseases.

We wish to thank David for taking the time to speak with us at the conference and for his work in supporting the development of rejuvenation biotechnology. 
CategoryInterviews, News
About the author

Elena Milova

As a devoted advocate of rejuvenation technologies since 2013, Elena is providing the community with a systemic vision how aging is affecting our society. Her research interests include global and local policies on aging, demographic changes, public perception of the application of rejuvenation technologies to prevent age-related diseases and extend life, and related public concerns. Elena is a co-author of the book “Aging prevention for all” (in Russian, 2015) and the organizer of multiple educational events helping the general public adopt the idea of eventually bringing aging under medical control.
About the author

Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 500 articles on the topic as well as attending various medical industry conferences. In 2019 he was listed in the top 100 journalists covering biomedicine and longevity research in the industry report – Top-100 Journalists covering advanced biomedicine and longevity created by the Aging Analytics Agency. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, and, Keep me Prime, and New Economy Magazine. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project. In 2015 he led the Major Mouse Testing Program (MMTP) for the International Longevity Alliance and in 2016 helped the team of the SENS Research Foundation to reach their goal for the OncoSENS campaign for cancer research.
Write a comment:


Your email address will not be published.

Privacy Policy / Terms Of Use

       Powered by MMD